Friday, December 4, 2015

Immunotherapy

"Using a patient’s own cells – identifying them, isolating them, expanding them, and infusing them back into the patient – is an exciting new pillar for drug development."

https://www.ucsf.edu/news/2015/11/328176/immunotherapy-type-1-diabetes-deemed-safe-first-us-trial

No comments:

Post a Comment